Journal Menu
► ▼ Journal Menu-
- Antibodies Home
- Aims & Scope
- Editorial Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
31 August 2022
Antibodies | Top 10 Cited Articles in 2021
1. “Antinuclear Autoantibodies in Health: Autoimmunity Is Not a Synonym of Autoimmune Disease”
by Irina A. Pashnina et al.
Antibodies 2021, 10(1), 9; https://doi.org/10.3390/antib10010009
Available online: https://www.mdpi.com/2073-4468/10/1/9
2. “Utilizing Immunocytokines for Cancer Therapy”
by Erin Runbeck et al.
Antibodies 2021, 10(1), 10; https://doi.org/10.3390/antib10010010
Available online: https://www.mdpi.com/2073-4468/10/1/10
3. “Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics”
by Xiaotian Zhong et al.
Antibodies 2021, 10(2), 13; https://doi.org/10.3390/antib10020013
Available online: https://www.mdpi.com/2073-4468/10/2/13
4. “From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry”
by Darja Kanduc
Antibodies 2021, 10(4), 36; https://doi.org/10.3390/antib10040036
Available online: https://www.mdpi.com/2073-4468/10/4/36
5. “Introduction to Antibody-Drug Conjugates.”
by Mark C. Pettinato
Antibodies 2021, 10(4), 42; https://doi.org/10.3390/antib10040042
Available online: https://www.mdpi.com/2073-4468/10/4/42
6. “Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets”
by Lokesh Agrawal et al.
Antibodies 2021, 10(1), 3; https://doi.org/10.3390/antib10010003
Available online: https://www.mdpi.com/2073-4468/10/1/3
7. “HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1”
by Marius Gramlich et al.
Antibodies 2021, 10(1), 11; https://doi.org/10.3390/antib10010011
Available online: https://www.mdpi.com/2073-4468/10/1/11
8. “Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer”
by Violet Y. Tu et al.
Antibodies 2021, 10(3), 25; https://doi.org/10.3390/antib10030025
Available online: https://www.mdpi.com/2073-4468/10/3/25
9. “An Immunoregulatory Role for Complement Receptors in Murine Models of Breast Cancer”
by Fazrena Nadia Md Akhir et al.
Antibodies 2021, 10(1), 2; https://doi.org/10.3390/antib10010002
Available online: https://www.mdpi.com/2073-4468/10/1/2
10. “Tinkering under the Hood: Metabolic Optimisation of CAR-T Cell Therapy”
by Yasmin Jenkins et al.
Antibodies 2021, 10(2), 17; https://doi.org/10.3390/antib10020017
Available online: https://www.mdpi.com/2073-4468/10/2/17